文献速递儿科影像技术与安全神经CTMRUS

儿科影像的成本效果分析:迄今为止的证据(或证据缺乏)

Cost-Effectiveness Analysis in Pediatric Imaging: The Evidence (or Lack Thereof) Thus Far.
PubMed 文献 · J Am Coll Radiol · 2019-11-30

该系统综述检索了1976年以来公开发表的诊断性成本效果分析(CEA)数据库,480篇中仅10篇涉及胎儿与儿科影像。10篇研究报道43个质量调整生命年权重,其中46.5%基于成人数据,均未从儿童获取效用值,也未纳入疾病对家庭生活质量的影响;37个增量成本效果比中7个(18.9%)为成本节约、6个(16.2%)为更贵且效果更差。作者认为未来研究应纳入疾病对家庭的影响。

要点

  • 480篇诊断性CEA中仅10篇针对胎儿与儿科影像,证据明显匮乏。
  • 10篇研究共报道43个效用权重,其中20个(46.5%)基于成人数据,无一项从儿童获取。
  • 所有研究均采用医疗付费方视角,未纳入患者自付费用(如误工、交通)。

核心结论

  • 评价儿科影像技术的成本效果研究明显匮乏,现有研究未纳入患者与家庭视角的效用(如疾病对家庭生活质量的影响)和费用(如误工、交通、请假时间),未来研究应获取并纳入疾病对家庭的影响以更好反映真实世界情况。

研究设计与样本

  • 系统综述,检索自1976年以来公开发表的成本效果分析(CEA)数据库,纳入所有涉及胎儿和儿科影像的CEA,共480篇诊断性CEA中10篇符合条件。

诊断标准与关键数值

  • 10篇研究共报道43个效用权重:基于既往成人数据20个(46.5%),孕妇视角11个(25.6%),治疗医师视角12个(27.9%)。
  • 37个ICER中,成本节约7个(18.9%),更贵且效果更差6个(16.2%)。
  • ICER范围从每质量调整生命年1400美元(新生儿隐匿性脊髓闭合不全中等风险,MRI对比超声)到每质量调整生命年1000万美元(颅缝早闭低风险儿童,CT对比不成像)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 现有研究均未从儿童获取效用权重,也未考虑疾病对家庭生活质量的产后影响。
  • 所有研究均采用医疗付费方视角,未纳入患者自付费用如误工损失或交通相关费用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To systematically review all published cost-effectiveness analyses (CEAs) of imaging technologies in children.

METHODS: We identified all CEAs involving fetal and pediatric imaging included in a publicly available repository of CEAs published since 1976. Information on publication characteristics, methods, costs, quality of life weights, and incremental cost-effectiveness ratios (ICERs) was recorded for each article.

RESULTS: Of 480 diagnostic CEAs, only 10 focused on fetal and pediatric imaging. The 10 studies reported 43 quality of life weights based on previously published adult data (n = 20, 46.5%); pregnant women perspective (n = 11, 25.6%), and treating physician perspective (n = 12, 27.9%). None of the studies elicited quality of life weights from children nor took into consideration the postnatal impact of disease on family's quality of life. All studies used a health care payer perspective without incorporating patients' incurred cost such as loss wages or travel related cost. Of 37 ICERs, 7 (18.9%) were cost saving and 6 (16.2%) were more expensive and less effective. The remaining ICERs ranged from $1,400 per quality-adjusted life-year (MRI versus ultrasound in newborns with moderate risk of occult spinal dysraphism) to $10,000,000 per quality-adjusted life-year (CT versus no imaging in children at low risk for craniosynostosis).

CONCLUSION: There is a striking paucity of cost-effectiveness studies evaluating imaging technologies in children. Existing studies do not incorporate the patient and family perspectives regarding utilities (eg, impact of child's disease on families' quality of life) or cost (eg, loss wages, travel, time off). Future studies should elicit and incorporate the impact of disease on families to better reflect real-world scenarios.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Otero HJ, Degnan AJ, Kadom N, et al. Cost-Effectiveness Analysis in Pediatric Imaging: The Evidence (or Lack Thereof) Thus Far. J Am Coll Radiol. 2019. PMID: 31790678. doi:10.1016/j.jacr.2019.10.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。